To define the role of T cells and B cells in resistance to vesicular stomatitis virus (VSV) infection, knockout mice with different specific immune defects on an identical background were infected i.v. and the outcome of infection was compared; in this way a more complete picture of the relative importance of various host defence mechanisms could be obtained. Compared to T and B celldeficient SCID mice which all succumbed from encephalitis within 5-9 days of infection, T celldeficient nude mice generally lived longer, but within a period of~1 month after challenge all died. In contrast, B cell-deficient mice were highly susceptible even to low doses of virus and mortality could be prevented by transfer of naive B cells prior to challenge as well as by immune serum given after challenge. Analysis of MHC class I-and class II-deficient mice revealed that CD8 ⍣ T cells could exert some antiviral activity, but CD4 ⍣ T cells sufficed for survival and were required for optimal resistance. Consistent with this it was found that in nude mice a lethal outcome could be prevented by transfer of CD8-depleted cells from B cell-deficient mice. Thus our results clearly demonstrate that while antibodies are pivotal for survival in the early phase of VSV infection, T cells are required for long-term survival, with CD4 ⍣ T cells being more effective in controlling this infection than CD8 ⍣ T cells.
Introduction
Cell-mediated immunity is generally believed to play a pivotal role in the control of acute viral infections (1) . Thus, the MHC class I-restricted CD8 ϩ cytotoxic T lymphocyte (CTL) response has been found to be important for the resolution of most experimental viral infections (2), although results from several model systems have recently disclosed that in its absence, many viral infections may be controlled by a compensatory CD4 ϩ T cell response (3) (4) (5) (6) (7) . In contrast, humoral immunity is thought to contribute only marginally to the control of most primary viral infections, whereas reinfection with the same viruses may be effectively prevented by preformed antibodies (1, (8) (9) (10) . This view is supported by observations in humans with defects in either T cell or B cell function. Thus, in general, primary viral infections do not take a more severe course in B cell-deficient patients, whereas patients with deficiencies in T cell function are highly susceptible to a number of viral infections (11) . However, there are some observations which indicate that there may be relevant exceptions to this rule. Thus, patients with B cell deficiencies are at much higher risk of developing paralytic complications from enteroviral infections than are B cell competent individuals (12) . Also, certain types of experimentally induced viral encephalitides may be effectively controlled even in nude mice with few or no T cells (13) (14) (15) . Together these observations could suggest that antibodies may be of particular importance in controlling viral infections of the central nervous system (CNS) and/or the spread to this organ. From a vaccine point of view this is very important and the present study was therefore undertaken to clearly define the importance of antibodies relative to other components of the specific immune response, in controlling viral infections characterized by spreading to CNS.
Murine infection with vesicular stomatitis virus (VSV) was used as a model system. VSV is a cytopathic virus (16) that belongs to the Rhabdoviridae and it is a close relative of rabies virus, resembling the latter in a high affinity for neuronal infection (17, 18) . Thus, although a potent IFN-αβ response effectively inhibits the initial virus replication in peripheral organs (19, 20) , the virus will reach the CNS in the absence of a specific immune response and immunodeficient mice will develop a paralytic disease from which they die 5-10 days post-infection (p.i.) (21) . In immunocompetent mice, VSV induces a CTL response which peaks around day 6 p.i. (22) and a rapid IgM response that around day 6-8 p.i. is switched to a T cell-dependent IgG response (23, 24) . Since it has been reported that nude mice are resistant to paralytic disease (24) , it has been inferred that antibodies suffice for protection against a lethal outcome of this infection. However, a protective role for antibodies in T cell-deficient mice does not disclose their real physiological importance, since in normal animals the antibody response could simply be one of several resistance mechanisms induced by the virus (25) .
The aim of our study was therefore to determine the antiviral capacity of T cell subsets relative to B cells. This was done by comparing the outcome of VSV infection in mice with complete or partial T cell defects to that in mice made deficient in B cells by targeted disruption of the transmembrane exon of the Ig µ chain gene (µMT/µMT mice) (26) . Furthermore, by adoptive transfer of cells or serum into the latter mice, we sought to determine if B cells were needed as antigenpresenting cells or as a source for antibody production. Our results show clearly that antibodies play an indispensable role in the early phase of i.v. infection with VSV, primarily by preventing the spread of virus to the CNS. However, T cells are also required to prevent a lethal outcome and, although CD4 ϩ T cells suffices for long-term survival, even CD8 ϩ T cells appear to have some effect.
Methods

Mice
Female C57BL/6, C57BL/6-nu/nu, C.B-17 SCID, BALB/cA and BALB/cA-nu/nu mice were purchased from Bomholtgaard (Ry, Denmark). MHC class I (β 2 m-/-) and class II (A β -/-) deficient mice and matched wild-type controls were from Taconic Farms (New York, NY). Mice deficient in production of IFN-γ (IFN-γ-/-) were the progeny of breeding pairs (C57BL/ 6-IfgϽtm1Ͼ) from the Jackson Laboratory (Bar Harbor, ME). Homozygous µMT/µMT mice were produced locally from breeding pairs originating from NIH (Bethesda, MD). These mice had been back-crossed 7 times to a C57BL/6 background followed by back-crossing 3 times to a C57BL/10 background. Mutants and their wild-type littermates were from brotherϫsister matings using homozygous males and heterozygous females, and the offspring were selected by testing sera in a sandwich ELISA for presence of IgM antibodies. In some cases B cell status was also evaluated by flow cytometry using anti-CD45R(B220) and the expected pattern was always confirmed. All mice were housed under specific pathogen-free conditions and sentinels were tested regularly according to FELASA guidelines; no unwanted infections were detected. Mice from outside sources were always allowed to rest for at least 1 week before entering an experiment; by that time the animals were~7-8 weeks old.
Virus and virus quantitation
VSV of the Indiana strain originally provided by K. Berg of this institute was used in all experiments. Virus quantitation was performed on L929 cells (ATCC CCL 1) plated 48 h earlier in Petri dishes in Eagle's minimal essential medium (F11) containing 10% FCS, glutamine, antibiotics (penicillin and streptomycin) and 5% NaHCO 3 . Medium was aspirated, and 1 ml of serial 10-fold dilutions of virus was transferred to the monolayers and virus adsorption was allowed to proceed for 90 min at 37°C in 5% CO 2 . Medium was then aspirated, and monolayers were overlaid with a mixture of 2.5 ml 1% agarose (SeaKem; Medinova Scientific Aps, Hellerup, Denmark) and 2.5 ml 2ϫF11 medium. Following incubation at 37°C in 5% CO 2 for 24 h, cells was stained by adding a mixture of 1 ml 1% agarose and 1 ml 2ϫ F11 medium containing 1% neutralred. Cultures were then incubated further for 24 h and the number of p.f.u. was counted. In cases where virus titers in organs were determined, starting material was a clarified 10% organ suspension.
Virus infection
Unless otherwise specified, mice to be infected received a virus dose of 1ϫ10 6 p.f.u. of VSV in an i.v. injection of 0.3 ml. In some cases mice were infected intracerebrally (i.c.), in the footpad (f.p.) or intranasally (i.n.) by inoculation of 0.03 ml of virus. For formalin inactivation, a final concentration of 0.0625% was used and the mixture was incubated at 4°C for 16 h as previously described (23); before injection, virus was diluted so that 0.3 ml (1ϫ10 7 p.f.u.) could be injected i.v.
Survival study
Mortality was used to evaluate the clinical severity of acute VSV-induced paralysis. Mice were checked daily for clinical symptoms and sacrificed when severe paralysis was noted, and the animals were expected to die within 24 h according to previous experience.
Reconstitution of µMT/µMT mice with B cells
Spleen cells from phenotypically normal littermates were depleted of Thy-1 ϩ cells and 1ϫ10 8 cells (one spleen equivalent) were transferred to µMT/µMT mice 7 days before infection with VSV.
Depletion of T cell subsets prior to adoptive transfer
Donor cells for adoptive transfer were depleted of T cells by complement-mediated cytolysis (anti-Thy-1.2 or anti-Ly-2.2) prior to adoptive transfer as recommended by the manufacturer (Cedarlane, Ontario, Canada). Cell numbers were based on pretreatment numbers without compensation for cell losses. In parallel experiments, these antibody depletions were shown to eliminate responsiveness to concanavalin A and virus-specific cytotoxicity respectively.
Depletion of T cells in vivo
Mice were given a dose of 0.1 mg of anti-Thy-1 i.v. on day 0 and day ϩ1 relative to virus inoculation; in parallel experiments this regimen was found to markedly inhibit the T cell response to infection with lymphocytic choriomeningitis virus (data not shown). 
Serum neutralization test
Two-fold dilutions of serum were mixed with equal volumes of virus diluted to contain~100 p.f.u./ml. After incubation for 1 h at room temperature, the mixtures were transferred onto monolayers of L cells for titration of virus content as described above. The neutralizing titer was taken as the highest serum dilution that reduced the number of plaques by at least 50%. To determine IgG titers, serum was preincubated with 0.1 M of 2-mercaptoethanol for 1 h at room temperature; this treatment has been shown to eliminate only IgM, but not IgG from serum (27) . Unreduced samples were taken as IgM titers only, if corresponding reduced samples had at least a 4-fold lower titer (23) .
Results
T cells are critical for long-term survival
In a first experiment ( Fig. 1) , SCID, nu/nu and wild-type mice on a BALB background were inoculated i.v. with 1ϫ10 6 p.f.u. of VSV, and the effect of this challenge was monitored for 21 days. Confirming previous observations, all SCID mice had succumbed to paralytic disease by day 10 p.i. showing that the innate immune response was incapable of controlling this dose of virus. However, to our surprise a significant proportion of nude mice also succumbed to this challenge, albeit in a somewhat delayed fashion compared to SCID mice. Thus, although comparison of the course of the infection in SCID and nu/nu mice indicates that B cells have some antiviral capacity on their own, it is evident that T cells are also required for optimal resistance.
Role of lymphocyte subsets in preventing a lethal outcome of i.v. infection with VSV
To more precisely define the role of T cells relative to that of B cells, the following mutants were infected with VSV: MHC class I-and class II-deficient mice (deficient in CD8 ϩ and CD4 ϩ T cells respectively), nude mice lacking most mature T cells, and µMT/µMT mice deficient in B cells. In addition, as IFN-γ is a central antiviral cytokine produced by both major T cell subsets, mice deficient in production of this cytokine (IFN-γ-/-) were also challenged with VSV. Since all the mutants were on the same background (C57BL), the outcome of VSV infection could be directly compared. As seen in Table 1 , all µMT/µMT mice rapidly succumbed to the infection. In contrast, although all nude mice also eventually died from paralytic disease, the majority survived longer than B cell-deficient mice (see also Fig. 2 ) indicating that the transient T cellindependent IgM response in these mice has some antiviral capacity. The majority of mice with partial T cell defects survived, with class II-deficient mice being most susceptible (58% survival). It is noteworthy that no persistent antibody response was detected in surviving class II-deficient mice, thus indicating that the critical T cell function in these mice is provided by CD8 ϩ T cells and not the residual population of CD4 ϩ cells present in these mice (28) .
To further compare the importance of T and B cells, µMT/ µMT mice and nude mice were infected with a range of different doses of VSV (10 4 , 10 5 and 10 6 p.f.u.), and the outcome of infection was followed (Fig. 2) . Wild-type littermates infected with 10 6 p.f.u. served as control; none of these died. From these results (Fig. 2) it is evident that B cells are absolute essential for survival during the early phase of VSV infection: only 20% of µMT/µMT mice challenged with the lowest virus dose (10 4 p.f.u.) survived the infection and all µMT/µMT mice infected with higher doses of virus succumbed to the infection. In contrast, T cell-deficient mice generally survived longer and at the lower doses not all died.
However, although B cells are mandatory for prevention of a lethal outcome, T cells might still be able to slow down progression of the infection. To test this possibility, µMT/µMT mice were infected with a relatively low dose of VSV (10 4 p.f.u.) and half the mice were depleted of T cells using antiThy-1.2. No acceleration of disease progression was observed (data not shown). Thus under the conditions studied, T cells alone appear unable to substantially affect survival. Taken together the above findings indicate that while B cells are the single most important component of the specific immune system required for survival during the early phase of VSV infection, T cells are required for long-term survival.
Reconstitution of the B cell compartment in µMT/µMT mice restores resistance to VSV infection
Since absence of B cells might indirectly affect the formation of the T cell repertoire, it had to be excluded that the failure of µMT/µMT mice to control the VSV infection could be a result of some T cell defect. Therefore, µMT/µMT mice were reconstituted with one spleen equivalent of Thy-1.2-depleted cells from naive wild-type mice and infected 7 days later with (24) . µMT/µMT mice given PBS and wild-type mice infected in parallel served as controls. As seen in Fig. 3 , normal serum did not prevent a lethal outcome in µMT/µMT mice, whereas serum from day 5 infected animals slightly delayed the onset of disease in half the animals. In contrast to day 5 serum, day 14 serum did confer resistance in 75% of the treated animals. Thus, apparently early IgM antibodies could only slightly delay the virus spread to the brain, whereas IgG antibodies were much more effective and given at this early time point would prevent lethal disease in most of the animals. However, although establishing the in vivo antiviral capacity of antibodies, the timing in the above experiment was clearly unphysiological. Therefore, in order to better mimic the natural course of the antibody response (24), the experiment was repeated (Fig. 4) giving either normal serum or day 5 serum on day ϩ1, followed by either day 5 or day 14 serum on day ϩ3 p.i., thus trying to mimic the isotype switch normally occuring in T cell competent mice. Whereas two doses of day 5 serum failed to permanently rescue any of the treated mice, day 5 serum followed by day 14 serum in two experiments protected 90% of the challenged mice. Normal serum followed by day 14 serum was protective in one, but not the other of two identical experiments. We believe that this reflects that the virus spread is reaching a critical limit about day 3-4 after the infection [cf. the variation in brain titers at this time point (Fig. 7) ], which is prevented in mice given day 5 serum 2 days earlier.
Virus spread to CNS is prevented in B cell competent mice
As a first approach to understand how antibodies could prevent a fatal outcome, organ virus titers in wild-type mice, µMT/µMT mice and µMT/µMT mice treated with immune serum (day 5 plus day 14 serum) were evaluated on day 7 p.i. While no virus was detected in organs of infected wild-type mice, µMT/µMT mice harbored high levels of virus in the CNS and kidneys, and even in the liver, lungs and spleen low amounts of VSV were found (10-500 p.f.u./ml organ suspension) in these mice. Treatment with immune serum either totally eliminated or very markedly reduced the virus load in all these organs ( Fig. 5 and not shown) . To further study the correlation between antibody levels, virus titers and outcome of infection, nude mice were infected i.v. and the antibody response of these mice was compared to the level of virus infection in the organs and clinical status (Fig. 6 ). On day 6 p.i., no virus was found in the brains of four nude mice and correspondingly moderate levels of neutralizing antibodies were present. On day 10 p.i. the antibody level had started to decline (24) and two out of three nude mice analyzed had VSV in the brain, one was clinically affected. On day 14 p.i., out of three randomly selected nude mice, one had high levels of virus in the brain and was clinically affected while two were negative and without symptoms. At no time point did we detect substantial amounts of virus in organs other than CNS. As this somewhat erratic pattern of virus isolation from the CNS was likely to reflect the wide range in time to death in nude mice, a slightly different approach was used in a repeat experiment. Here, VSV-infected nude mice were sacrificed at the time of appearance of clinical symptoms (included in Fig.  6) . Analysis of virus level in CNS revealed that all clinically affected nude mice had high levels of virus in the brain. In contrast, none of four wild-type mice analyzed on day 14 p.i. harbored detectable virus (not shown). These results suggested that the primary role of IgM antibodies was to prevent the virus from reaching the brain. If this assumption was correct, it would be expected that a difference between µMT/µMT mice and wild-type mice would be found only if virus inoculation was carried out at a distance from this organ.
To test this prediction, µMT/µMT and wild-type mice were infected i.v., f.p. or i.n., and mortality was recorded ( Table 2) . Independent of the route of virus inoculation, µMT/µMT mice died from virus challenge, whereas both i.v. and f.p. infections were effectively controlled in most wild-type mice. In contrast, following i.n. inoculation four out of five wild-type mice succumbed to the infection within the same time frame as did µMT/µMT mice.
Based on these findings we decided to compare the antibody response and viral titers in the brain of i.v. infected mice with those in i.n. infected mice (Fig. 7) . Whereas little or no difference in the antibody response of i.v. and i.n. infected wild-type mice was detected, the course of viral infection differed markedly between these groups. Thus, hardly any difference in levels of virus infection between µMT/µMT and wild-type mice was noted following i.n. infection, whereas in the case of i.v. infection with one exception only B celldeficient mice harbored virus in the brain at any time point studied. Thus, despite the development of a potent antibody response following i.n. infection, no substantial curtailing of virus replication in the brain was seen. As this route of inoculation allows direct access to CNS, these results strongly indicate that the amounts of antibodies produced during the natural development of the immune response are ineffective in controlling VSV infection if it reaches the brain at an early stage.
To further evaluate the potential of the early antibody response to control viral replication inside the brain, i.v. primed wild-type mice were challenged i.c. and the outcome of infection was evaluated (Table 3) . Since it could be expected that in i.v. infected mice virus would not reach the brain immediately, some of the mice were primed i.v. with either live or formalin inactivated virus 3 days before i.c. challenge. Whereas all wild-type mice challenged at the time of i.v. infection died, mice primed with live virus 3 days earlier resisted a low dose (10 p.f.u.) of virus, but succumbed to a moderate dose (1000 p.f.u.). In contrast, most mice (75%) primed with formalin-inactivated virus succumbed even to the low dose despite having similar neutralizing antibody titers on day 3 p.i. (1:3200-1:6400 in both groups). Since formalininactivated virus have previously been found only to prime B cells for IgM production (32) , this pattern indicates that early IgM antibodies have very limited capacity to control VSV infection once it is inside the CNS and, furthermore, that T cell-dependent effector mechanisms can only catch up with the infection provided that the viral load inside CNS is kept low.
Prevention of a fatal outcome in nude mice
From the previous results it could be expected that transfer of either CD4 ϩ T cells or neutralizing IgG antibodies would Organ titers in wild-type mice, µMT/µMT mice and µMT/µMT mice given VSV immune serum (0.2 ml day 5 serum on day ϩ1 and 0.5 ml day 14 serum on day ϩ3). Organs were analyzed on day 7 p.i. and data from individual mice are presented. suffice for long-term survival of nude mice, whereas neutralizing IgM antibodies would be of limited effect. To test this, groups of VSV-infected nude mice were passively immunized on day ϩ3 p.i. with either day 5 serum, day 14 serum or VSVprimed CD4 ϩ cells; a control group received only virus. As shown in Fig. 8 , reconstitution of the CD4 ϩ T cell compartment with CD8-depleted cells from µMT/µMT mice prevented VSV encephalitis in nude mice, demonstrating that B cells together with CD4 ϩ T cells suffice for resistance to this infection, and in addition confirming that the latter subset is functionally competent in µMT/µMT mice (antibody titer: 1:3200-6400; 2-mercaptoethanol resistant). A single injection of neutralizing IgG antibodies also had a marked effect, whereas injection of serum containing neutralizing IgM antibodies did not substantially change the course of VSV infection in nude mice.
Discussion
The results presented in this report provide clear evidence that virus-specific antibodies are needed to prevent early spreading of VSV to the CNS and a fatal outcome. Thus in this respect our results confirm and extend a recent report showing that B cell-deficient mice are more susceptible than normal mice to challenge with VSV (33) . The susceptibility of µMT/µMT mice is not due to a general defect of antiviral immunity in these mice, since infection with several other viruses is effectively controlled (8, 10, 34, 35) . Furthermore, both VSV-specific CTL (not shown) and helper T cells (Fig. 8) could be induced. More important, confirming the specificity of the defect, we could show that reconstitution with naive B cells prior to virus challenge restores resistance to i.v. challenge. Finally, we demonstrate that serum treatment mimicking the natural development of the antibody response has the In each of these groups, one mouse had paralysis of hind limbs by the end of the observation period, but no progression of disease had occured over the last week prior to termination of the experiment.
c All mice died within the same time frame (days 4-9 p.i.). same effect. From the comparison of i.n. and i.v. infected mice it seems reasonable to conclude that the primary role of the early antibodies is to prevent the virus from reaching the CNS. Thus, while the antibody response in i.n. and i.v. infected wild-type mice is essentially similar, virus replication in the brain is not substantially curtailed in the former. This conclusion is supported by the finding that i.c. challenge with a low dose of virus leads to fatal disease even in mice having neutralizing IgM antibodies. However, although B cells are absolutely necessary for prevention of early encephalitis, they are not sufficient for long-term survival. Thus, our findings clearly demonstrate that T cells are mandatory for long-term prevention of disease following i.v. infection with VSV. This is important since the role of T cells in peripheral infection with VSV has been somewhat elusive. In an early study it was found that nude mice resisted challenge with high doses of virus (24) , but in later studies the same group reported that cyclosporin A-treated mice (which treatment was demonstrated only to affect T cells, not B cells) as well as CD4 knockout mice were more susceptible than normal animals (21, 36) . The comparison of the outcome of VSV challenge in MHC class I-and class II-deficient mice clearly reveals that, in contrast to what is found in most acute viral infections, class IIrestricted (CD4 ϩ ) T cells are in this case more critical than class I-restricted (CD8 ϩ ) T cells, although some redundancy is apparent. Thus our findings extend earlier studies carried out in subset-depleted mice infected i.n. (16) . In the case of i.v. infection, the primary function of VSV-specific T cells may be to provide the help to B cells required for isotype switching and a sustained antibody response (23) . This conclusion is supported by the results obtained in nude mice in which the IgM response is sufficient to significantly delay the virus spread and onset of disease, but does not prevent late mortality. In this case, adoptive transfer of virus-primed CD4 ϩ T cells from µMT/µMT mice suffices to confer solid resistance and a single injection of neutralizing IgG antibodies markedly delays lethal disease. That T-B interaction constitutes an important component required for complete resistance is also indicated by the a recent report in which mice with a targeted mutation of CD40L were found to be partially susceptible to infection with VSV and this correlated with impaired Ig class switching (37) . Furthermore, our own preliminary studies have revealed a striking similarity between the disease pattern in CD40L knockout mice and MHC class II knockouts (data not shown). One reason why T cell help is critical to a protective humoral immune response is probably that in the absence of T-B interaction only a transient antibody response is induced (24) . Therefore, if no T cell help is delivered, the virus may temporarily be kept in check, but when the antibody response subsides, virus spreading to the CNS will take place. Consistent with this interpretation, we find no virus in the brain of nude mice early after virus inoculation, whereas high levels of virus are detected later on when clinical symptoms are also observed. Perhaps equally important, T cells control isotype switching (23, 24) , and IgG antibodies are likely to penetrate tissues and control the infection more efficiently than IgM antibodies (38) . Whether CD4 ϩ cells are required to perform other functions besides helping B cells is not clear at present. Evidently the capacity to produce IFN-γ is redundant in otherwise immunologically intact mice (Table 1) .
In contrast to CD4 ϩ T cells, class I-restricted T cells are superfluous in otherwise immunocompetent mice; this is not so surprising given that perforin-deficient mice are resistant to i.v. infection with VSV (39) . Furthermore, BALB/c-H-2 dm2 mice which lack the major class I restriction element (L d ) are more resistant to i.n. infection than are wild-type BALB/c mice Fig. 8 . Protection of nude mice challenged with 10 6 p.f.u. of VSV. On day ϩ3 p.i., nude mice were given either 5ϫ10 7 CD8-depleted donor cells from µMT/µMT mice (CD4 ϩ cells) primed 6 days earlier, 0.5 ml day 5 serum i.p., 0.5 ml day 14 serum i.p. or were left untreated. Groups consisted of five mice. Mice given CD8-depleted cells were sacrificed for analysis of T cell subset composition in the spleen on day ϩ28 p.i.; only CD4 ϩ T cells were found (median of group: 12.6% CD4 ϩ cells and Ͻ2% CD8 ϩ cells). (40) . However, in the absence of T helper cells, a significant antiviral potential of class I-restricted T cells is revealed: more than half of MHC class II-deficient mice survive i.v. infection with a dose of VSV which is invariably lethal to nude mice. Although this could have reflected that the small subset of CD4 ϩ T cells remaining in these mice had provided the signals needed for Ig class switching and a permanent antibody response, analysis of antibody levels in surviving mice confirmed that no durable antibody response was induced (41) . Therefore, it is most likely that class I-restricted T cells-although not mandatory for protection-are able to exert some direct (i.e. antibody-independent) antiviral activity provided that the initial virus spreading is curtailed by neutralizing (IgM) antibodies. Consistent with this interpretation, previous studies in i.n. infected mice have revealed some increase in viral titers, if CD8 ϩ T cells are depleted (16) . This might also explain why no late deaths are found in serumtreated µMT/µMT mice, whereas serum treatment only delays mortality in nude mice (cf. Figs 7 and 8 ).
In conclusion, the specific immune mechanisms critical to prevention of fatal VSV infection (with an absolute requirement for B cells early in the infection and emphasis on CD4 ϩ T cells latter on) appear to be strikingly different from those which apply in the case of, for example, infection with LCMV. In the latter case cytolytic CD8 ϩ T cells are mandatory for controlling the acute phase of the infection while CD4 ϩ T cells and B cells are required for permanent virus control (35) . Although it is not absolutely clear why these differences exist, there are two important distinctions between these infections that may be decisive. First, VSV has the capacity to rapidly induce a potent T cell-independent neutralizing antibody response. Second, while in the case of LCMV infection the target organs (spleen, lungs and liver) are directly infected by the initial introduction of the virus, VSV probably only reaches its critical target organ-the CNS-at a later stage of the infection (cf. that even a low dose of VSV injected directly i.c. leads to death). Together these features of the VSV infection would allow the time needed for the development of protective antibodies that would prevent VSV from reaching the CNS. The reason why cytolytic T cells are relatively inefficient against this infection may be the rarity of infected cells in the periphery, making these difficult for the effector T cells to target, perhaps combined with the low expression of MHC class I on neurons. Despite the differences it appears common to both models that a complex host response is needed to completely control the infection. Consequently, the results from these and other viral models strongly imply that one should be very careful in making simplified statements pointing to a single effector arm as being the sole factor determining the outcome of a viral infection. The implications for the design of future vaccines is therefore that unless the available evidence directly advises against it, as broad a host response as possible should be induced.
